PROCTER & GAMBLE HEALTH | MEDICO REMEDIES | PROCTER & GAMBLE HEALTH/ MEDICO REMEDIES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 55.5 | 62.3% | View Chart |
P/BV | x | 10.6 | 8.8 | 119.8% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH MEDICO REMEDIES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
MEDICO REMEDIES Mar-23 |
PROCTER & GAMBLE HEALTH/ MEDICO REMEDIES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 87 | 6,170.9% | |
Low | Rs | 3,883 | 16 | 24,268.8% | |
Sales per share (Unadj.) | Rs | 740.7 | 16.9 | 4,376.8% | |
Earnings per share (Unadj.) | Rs | 138.2 | 0.9 | 15,839.2% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 1.2 | 12,924.5% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 5.3 | 8,471.9% | |
Shares outstanding (eoy) | m | 16.60 | 82.98 | 20.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 3.0 | 205.2% | |
Avg P/E ratio | x | 33.5 | 59.0 | 56.7% | |
P/CF ratio (eoy) | x | 29.8 | 42.9 | 69.5% | |
Price / Book Value ratio | x | 10.3 | 9.7 | 106.0% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 4,272 | 1,797.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 57 | 3,629.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 1,404 | 875.6% | |
Other income | Rs m | 184 | 41 | 450.2% | |
Total revenues | Rs m | 12,480 | 1,445 | 863.5% | |
Gross profit | Rs m | 3,247 | 95 | 3,424.5% | |
Depreciation | Rs m | 281 | 27 | 1,032.7% | |
Interest | Rs m | 8 | 7 | 103.1% | |
Profit before tax | Rs m | 3,142 | 101 | 3,111.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 29 | 2,965.7% | |
Profit after tax | Rs m | 2,295 | 72 | 3,168.6% | |
Gross profit margin | % | 26.4 | 6.8 | 391.1% | |
Effective tax rate | % | 27.0 | 28.3 | 95.3% | |
Net profit margin | % | 18.7 | 5.2 | 361.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 662 | 1,770.1% | |
Current liabilities | Rs m | 6,791 | 432 | 1,573.6% | |
Net working cap to sales | % | 40.0 | 16.4 | 244.2% | |
Current ratio | x | 1.7 | 1.5 | 112.5% | |
Inventory Days | Days | 263 | 3 | 10,018.2% | |
Debtors Days | Days | 343 | 938 | 36.6% | |
Net fixed assets | Rs m | 10,617 | 229 | 4,634.4% | |
Share capital | Rs m | 166 | 166 | 100.0% | |
"Free" reserves | Rs m | 7,265 | 272 | 2,666.3% | |
Net worth | Rs m | 7,431 | 438 | 1,694.8% | |
Long term debt | Rs m | 0 | 2 | 0.0% | |
Total assets | Rs m | 22,330 | 891 | 2,506.7% | |
Interest coverage | x | 409.1 | 14.5 | 2,817.3% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.6 | 1.6 | 34.9% | |
Return on assets | % | 10.3 | 9.0 | 115.0% | |
Return on equity | % | 30.9 | 16.5 | 187.0% | |
Return on capital | % | 42.4 | 24.6 | 172.3% | |
Exports to sales | % | 0 | 88.0 | 0.0% | |
Imports to sales | % | 13.1 | 8.6 | 151.5% | |
Exports (fob) | Rs m | NA | 1,236 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 121 | 1,326.6% | |
Fx inflow | Rs m | 1,465 | 1,236 | 118.5% | |
Fx outflow | Rs m | 1,605 | 124 | 1,290.6% | |
Net fx | Rs m | -140 | 1,112 | -12.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 82 | 2,889.7% | |
From Investments | Rs m | -215 | -66 | 325.6% | |
From Financial Activity | Rs m | -985 | -18 | 5,419.4% | |
Net Cashflow | Rs m | 1,160 | -3 | -45,681.1% |
Indian Promoters | % | 0.0 | 73.3 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 1.0 | 1,938.8% | |
FIIs | % | 6.2 | 0.3 | 2,151.7% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 26.7 | 180.7% | |
Shareholders | 56,778 | 10,685 | 531.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | MEDICO REMEDIES | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | -0.53% | 0.45% |
1-Month | -1.15% | 0.63% | 2.55% |
1-Year | 0.73% | -41.90% | 56.14% |
3-Year CAGR | -8.76% | 108.99% | 15.22% |
5-Year CAGR | 4.97% | 60.29% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the MEDICO REMEDIES share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of MEDICO REMEDIES the stake stands at 73.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of MEDICO REMEDIES .
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
MEDICO REMEDIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of MEDICO REMEDIES .
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.